FREMONT, Calif., Feb. 24, 2025 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the release of the ...
Creative Biolabs, a global leader in integrated biotechnology solutions, today announced the strategic expansion of its ...
Learn best practices for HTS assay development, including validation, robustness, and Z-prime optimization for reliable ...
Jeff Borgia, Ph.D. is the Director of the Rush Cancer Center Biorepository, where he oversees the collection and annotation of patient specimens in support of ongoing translational research projects ...
SAN DIEGO--(BUSINESS WIRE)--PhenoVista Biosciences, a contract research organization (CRO) and leading provider of both custom and off-the-shelf, imaging-based assay services based in San Diego, ...
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today a series of enhancements for its QIAcuity series of digital PCR (dPCR) ...
Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseasesManchester, UK, and Cambridge, UK, 24 March 2026: Primerdesign (part of the ...
First in human (FIH) clinical trials of bispecific immunostimulatory antibodies commonly require a low starting dose based on a minimum anticipated biological effect level (MABEL) approach. To ...
Precision medicine is driven by advances in omics technologies that facilitate identification of mutations and the presence or absence of certain molecular targets, which, in turn, enables streamlined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results